WAVE Life Story

WAVE Life Sciences Ltd -- USA Stock  

USD 52.25  2.45  4.48%

Macroaxis does not monitor all media channels or aggregates social signals for WAVE Life. But even though we do not provide professional-grade financial sentiment analysis on WAVE Life Sciences, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for WAVE Life. See also WAVE Life Hype Analysis, WAVE Life Correlation and WAVE Life Performance
WAVE Life exotic insider transaction detected
Filed transaction by Wave Life Sciences Ltd director. Unconventional Insider trading

WAVE Life Sciences Ltd insider trading alert for general transaction of series b preferred shares by Ken Takanashi, the corporate stakeholder, on October 6, 2017. This event was filed by Wave Life Sciences Ltd with SEC on 2015-11-10. Initial filing of beneficial ownership - SEC Form 3. Ken Takanashi is currently serves as corporate secretary and director of WAVE Life Sciences

Story Momentum

This article from MacroaxisInsider published on 06 of October contributed to the next trading period closing price depreciation.The trading price change to the next next day price was 4.60% . The trading price change when the story was published to current price is 109.60% .

Similar stores for WAVE Life

2 days ago at http://www.equities.com 
WAVE Life Sciences Ltd. Breaks into New 52-Week High on February 16 Session
Equities News
Shares of WAVE Life Sciences Ltd. broke into a new 52-week high yesterday, hitting a peak of 55.00. Shares closed at 54.70 after opening at 52.40 for a move of 4.69. Analysts Give These Stocks Mix Nod WAVE Life Sciences Ltd. , Cytori ... - Post Analyst Wave Life Sciences Ltd Position Lifted by Schwab Charles ... - The Ledger Gazette
over a month ago at http://ledgergazette.com 
Wave Life Sciences Ltd Receives Consensus Recommendation of Buy from ...
Wave Life Sciences logo Wave Life Sciences Ltd has earned a consensus recommendation of Buy from the eight research firms that are presently covering the firm, MarketBeat Ratings reports. Breaking Mizuho Securities Reiterates 34.0 Target Price On Wave Life ... - BZ Weekly WAVE Life Sciences Ltd. Reaches 35.10 After 6.00 percent Up Move Last Week ... - UtahHerald.com
over two months ago at http://ledgergazette.com 
WAVE Life Sciences Ltd. Releases Earnings Results, Beats Expectations By ...
WAVE Life Sciences logo WAVE Life Sciences Ltd. released its quarterly earnings results on Thursday, November 9th. WAVE Life Sciences Ltd. Upgraded to Hold by BidaskClub - StockNewsTimes WAVE Life Sciences Ltd. Given Outperform Rating at Leerink Swann - TrueBlueTribune
over three months ago at http://www.hugopress.com 
WAVE Life Sciences Ltd. Ordin Experiences Heavy Trading Volume
WAVE Life Sciences Ltd. - Ordin shares had a trading volume of 146K by the end of trading on Tuesday. Trading volume was up 122.36 percent over the stocks average daily volume. WAVE Life Sciences Ltd. Ordin Sees Significantly Higher Trading ... - Modern Readers How Have WAVE Life Sciences Ltd. EPS Forecasts Changed - Analyst Journal

Did you try this?

Run Bollinger Bands Now

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
Hide  View All  NextLaunch Bollinger Bands

Short Ratio

Short Ratio Comparative Analysis
  Short Ratio 
      WAVE Life Comparables 
WAVE Life is currently under evaluation in short ratio category among related companies. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.